NDC Package 49591-126-51 Varizig

Human Varicella-zoster Immune Globulin Injection, Solution Intramuscular - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
49591-126-51
Package Description:
1 VIAL, GLASS in 1 CARTON / 1.2 mL in 1 VIAL, GLASS (49591-126-11)
Product Code:
Proprietary Name:
Varizig
Non-Proprietary Name:
Human Varicella-zoster Immune Globulin
Substance Name:
Human Varicella-zoster Immune Globulin
Usage Information:
This medication is used to help provide protection (antibodies) against a certain virus infection (varicella zoster) commonly known as chickenpox. It is used by certain people who have not been vaccinated or had the infection before and have had recent contact with someone infected with chickenpox. This medication is made from healthy human blood that has high levels of a certain substance (varicella zoster antibodies) which helps fight the infection. Routine vaccination is usually the best way to protect against infection.
11-Digit NDC Billing Format:
49591012651
NDC to RxNorm Crosswalk:
  • RxCUI: 1365979 - VARIZIG 125 UNT in 1.2 ML Injection
  • RxCUI: 1365979 - 1.2 ML varicella-zoster immune globulin 104 UNT/ML Injection [Varizig]
  • RxCUI: 1365979 - 1.2 ML Varizig 104 UNT/ML Injection
  • RxCUI: 1365979 - Varizig 125 UNT per 1.2 ML Injection
  • RxCUI: 252016 - varicella zoster immune globulin (human) 125 UNT in 1.2 ML Injection
  • Product Type:
    Plasma Derivative
    Labeler Name:
    Kamada Ltd.
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Sample Package:
    No
    FDA Application Number:
    BLA125430
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    03-01-2024
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 49591-126-51?

    The NDC Packaged Code 49591-126-51 is assigned to a package of 1 vial, glass in 1 carton / 1.2 ml in 1 vial, glass (49591-126-11) of Varizig, a plasma derivative labeled by Kamada Ltd.. The product's dosage form is injection, solution and is administered via intramuscular form.

    Is NDC 49591-126 included in the NDC Directory?

    Yes, Varizig with product code 49591-126 is active and included in the NDC Directory. The product was first marketed by Kamada Ltd. on March 01, 2024 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 49591-126-51?

    The 11-digit format is 49591012651. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-249591-126-515-4-249591-0126-51